Molecular subtyping can predict chemotherapy benefit in patients with colorectal canc
 

Molecular subtyping can help predict outcomes and chemotherapy benefit in patients with colorectal cancer, according to a presentation at the annual conference of the American Society of Clinical Oncology (ASCO).

More...

Re: Molecular subtyping can predict chemotherapy benefit in patients with colorectal
 

Any step toward personalized cancer treatment is in the right direction. Genomes, Phenomes, whatever makes an individual's cancer able to be treated more successfully with an increase in Quality of Life . . . bring it on!